Nowadays it is the Democrats who are (ahem!) the high- minded crowd, compared with their competition, the Republicans. Times change. This is Whitman ‘s take on the Democratic Party Convention in the US in the 1850s: “The members who composed it were, seven-eights of them, the meanest kind of bawling and blowing office-holders, office- seekers, …
This has never previously been seen anywhere else, and in any era, and is truly historic: subversion- by- exhaustion. I refer to the White House strategy of disgusting and exasperating all normal, decent supporters of thoughtful, informed and grown-up government, with the objective of getting them to stop paying attention to the daily, endless, infuriating …
Matt Scheckner is the founder of an Advertising Week jamboree, which was held recently in London. He is quoted as saying, “One of our biggest challenges is to make sure your advert doesn’t end up next to a recruitment video for Isis”. Online adverts via Google and Youtube et al have been appearing next to extremist …
Continue reading ‘Programmatic advertising: the Google comeuppance’ »
From The Times: What lay behind last year’s historic vote to leave the EU? As soon as the referendum was over, Brexit advocates began to claim it was all about “freeborn Englishmen and women casting off the EU’s federalising yoke”. No, says Clare Foges. To see the reality, you need only look at the polls …
Continue reading ‘Great Britain’s rising fury at a great betrayal’ »
From Sam Edge, Ringwood, Hampshire, UK Most of the cost of drug development comes from the public purse, not from the large pharmaceutical companies (3 June, p 22). Independent research has repeatedly shown that these companies spend only around 15 per cent of their revenue on research and development. Tellingly, most spend at least twice …
Continue reading ‘Drugs, part 2 : Should pharmaceutical reseach be under public control?’ »
